Cargando…
Nonalcoholic Fatty Liver Disease in Children and Adolescents Taking Atypical Antipsychotic Medications: Protocol for a Systematic Review and Meta-analysis
BACKGROUND: Atypical antipsychotics (AAP) are commonly prescribed to children and adolescents and are associated with important adverse effects including weight gain and metabolic syndrome. Nonalcoholic fatty liver disease (NAFLD) is not only the most common pediatric liver disease but is also assoc...
Autores principales: | Hatem, Reem, Nawaz, Faisal A, Al-Sharif, Ghadah A, Almoosa, Mohammad, Kattan, Wid, Tzivinikos, Christos, Amirali, E Lila, Albanna, Ammar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981001/ https://www.ncbi.nlm.nih.gov/pubmed/35311689 http://dx.doi.org/10.2196/20168 |
Ejemplares similares
-
Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
por: Xu, Haiyun, et al.
Publicado: (2019) -
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
por: Gilca, Marilena, et al.
Publicado: (2014) -
Two cases of neuroleptic malignant syndrome in elderly patients taking atypical antipsychotics
por: Feng, Yuhui, et al.
Publicado: (2013) -
Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics
por: Kang, Shi Hyun, et al.
Publicado: (2015) -
Ethnic and Age Disparities in Patients Taking Long-acting Injectable Atypical Antipsychotics
por: Soleman, Mateen, et al.
Publicado: (2017)